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Depression is now widely regarded as a common disabling disorder that affects
negatively the social functioning all over the world. Depression is associated with
diverse phenomenon in brain such as neuroinflammation, synaptic dysfunction, and
cognitive deficit. Recent studies reported that depression occurs by various metabolic
changes, leading to metabolic syndrome. Sirtuins (SIRTs) are NAD+-dependent class
III histone deacetylases, known to regulate diverse biological mechanism such as
longevity, genomic stability, and inflammation. The modulation of sirtuin activity has been
highlighted as a promising approach to reduce neurodegenerative processes. In this
review, we summarize the recent discoveries regarding the potential relationship between
SIRTs and depression caused by metabolic disorders (Mets). Ultimately, we suggest the
possibility that SIRTs will be novel targets to alleviate neuropathogenesis induced by
depression.
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INTRODUCTION
The prevalence of depression continues to rise all over the world and yearly prevalence rate
is close to 10% (Kessler et al., 2003, 2005, 2011; de Souza and Hidalgo, 2012). According
to the world health organization (WHO) ranks regarding depression, depression will be
the second leading cause of mortality worldwide in 2030 (Lopez and Mathers, 2006).
Moreover, the patients with depression showed decreased expression of synapse related
genes, the loss of synapse in hippocampus (Duric et al., 2013) and dendritic atrophy
associated with depression-like behaviors (Morales-Medina et al., 2013). Finally, 94% of
patients suffering from depression experience cognitive impairment (Conradi et al., 2011)
including impairment of executive functions, attention, memory and learning (Jaeger et al.,
2006; Murrough et al., 2011; Etkin et al., 2013; Trivedi and Greer, 2014). For these reasons,
the increase of patients with depression is an important issue in the view of economical
and sociological aspects. The causes of depression are mainly genetic factors (Lohoff, 2010),
aberrant inflammatory response (Miller et al., 2009; Dowlati et al., 2010; Harry and Kraft,
2012) and the insufficient level of neurotransmitters including cortisol (Miller et al., 1999),
serotonin (Maes et al., 2011), acetylcholine (Picciotto et al., 2015) and dopamine (Nutt, 2008).
Furthermore, current studies highlight that depression patients reportedly exhibit the positive
correlation with metabolic syndrome including diabetes and obesity (Pan et al., 2012; Silva
et al., 2012). People with metabolic disorders (Mets) have higher prevalence of depression
compared to those without metabolic syndromes (Pan et al., 2012; Sekita et al., 2013).
Sirtuins (SIRTs), which are known as the important metabolism regulator, were categorized
seven isoforms (SIRT1–7) characterizing by different substrate and subcellular localization
(Michan and Sinclair, 2007; Nakagawa and Guarente, 2011). All SIRTs have different length
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of N-and C- terminal extensions and play variable role in
mammal (Schwer et al., 2002; Tennen et al., 2010). SIRTs existed
in the nucleus (SIRT1, 6, 7), cytosol (SIRT2), and mitochondria
(SIRT3, 4, 5; Morris et al., 2011; Donmez and Outeiro, 2013).
Sirtuin’s expression increases in cells exposed to conditions of
oxidative stress and DNA damage (Cohen et al., 2004; Rodgers
et al., 2005). Especially, SIRTs modulate diverse biological
mechanisms including oxidative damage, protein aggregation,
and inflammatory responses associated with central nervous
system (CNS) diseases (Han, 2009) and play protective roles in
neuropathological condition (Paraiso et al., 2013). Interestingly,
a current study suggested that the expression of SIRT1, 2 and 6
mRNA in blood cells was altered in patients with mood disorders
such as depression (Abe et al., 2011). Also, hippocampal
SIRT2 enhances the depressant like behaviors by regulating
neurogenesis (Liu et al., 2015). Here, we summarized recent
evidences that SIRTs is involved in depressive disorder and SIRTs
contributes to improve the depressive symptoms associated
pathological phenomenon in metabolic stress condition. Thus,
our review suggests that SIRTs may be good candidate genes to
ameliorate the depressive symptoms.
SIRTUINS AND INFLAMMATION IN
DEPRESSION
In a third of patients with depression, the serum and
cerebrospinal fluid (CSF) concentrations of inflammatory
markers in serum showed the elevation of pro-inflammatory
factors such as interleukine (IL)-6, tumor necrosis factor
(TNF)-α, and C-reactive protein compared to non-depressed
patients (Raison et al., 2006; Dantzer et al., 2008; Dowlati
et al., 2010; Liu et al., 2012). One study demonstrated that
anti-depressants alleviate depressive state by suppressing the
production of pro-inflammatory mediators such as IL-6 and
nitric oxide (Hashioka et al., 2007). In addition, major depressive
disorder were observed the reduction of natural killer cell
cytotoxicity and T lymphocyte activity (Maes et al., 1991;
Wong et al., 2008; Blume et al., 2011; Karg et al., 2011).
In a clinical research, antidepressant treatment results in the
enhancement of inflammatory response such as the reduction of
IL-1 in depression patients and alleviates depressive symptoms
(Hannestad et al., 2011). Based on various evidences, major
depressive disorder leads to the inflammatory response including
the activity of natural killer cell and lymphocyte, and the
secretion of cytokines in brain. Hence, the decreased of
inflammation may be a one of the solution for depression.
SIRTs have known that they are involved in the inflammatory
mechanisms through anti-apoptotic pathways. SIRT1 modulates
the nuclear translocation of Forkhead box-containing protein O
(FoxO) which is associated with the anti-apoptotic factor Bcl2
(Daitoku et al., 2004; Hsu et al., 2010). SIRT1 enhances cell
survival in various stress conditions through the regulation
of several substrates (Vaziri et al., 2001; Bordone et al.,
2007). Several studies have mentioned the roles of SIRT1
as anti-apoptotic regulator that SIRT1 deacetylates the DNA
repair factor (Jeong et al., 2007; Anekonda and Adamus,
2008; Mallick and D’Mello, 2014), and also inhibits p53
and NF-κB signaling (Cheng et al., 2003; Hernandez-Jimenez
et al., 2013). Moreover, SIRT1 promotes growth of neurons
and inhibits the death of neurons in CNS through mTOR
signaling (Guo et al., 2011). SIRT1 also inhibits the release
of pro-inflammatory cytokines in microglia (Ye et al., 2013).
SIRT2 inhibits the inflammatory responses in CNS disorders
by controlling the activation of microglia (Chen et al., 2015).
SIRT2 prevents the excessive activation of microglia through
NF-κB deacetylation (Pais et al., 2013) and regulate the cell
cycle and the survival of microglia (Nie et al., 2014). SIRT3
protects cells against apoptotic cell death in oxidative stress
by regulating anti-apoptotic signaling (Pellegrini et al., 2012;
Chen et al., 2013) and by inhibiting the production of ROS
(Kim et al., 2010). SIRT3 protects cortical neurons against H2O2
stimulated oxidative stress by regulating mitochondrial Ca2+
homeostasis and mitochondria dysfunction (Dai et al., 2014;
Hu et al., 2014). Taken together, SIRTs have the pro-apoptotic
effect via various pathways and is the regulator of cytokine
secretion in CNS. Thus, we suggest that SIRTs may be strongly
involved in the inflammatory response, leading to depression
(Figure 1).
SIRTS AND NEUROTRANSMITTER’S
INSUFFICIENT LEVEL IN DEPRESSION
Depression has been reported that it is related with the alterations
of neurotransmitters such as serotonin (5-HT), norepinephrine
and dopamine (Nutt, 2008). In patients with depression, the
level and activity of neurotransmitter were founded insufficiently
compared to the normal subjects (Ruhe et al., 2007; Nutt, 2008).
Considering the clinical research, monoaminergic modulators
could improve the depressive symptoms in over 30–40% of
all population (Roiser et al., 2012). In the state of depression,
the level of serotonin, norepinephrine, and tyrosine known
as the precursor of dopamine were insufficiency in the
brain (Coppen, 1967) and in the blood of patients (Benkert
et al., 1971; Antkiewicz-Michaluk et al., 2014). Also, the
activity and level of dopamine associated with attention (Nutt,
2008) is dysregulated in major depressive disorders (Delgado,
2000; Dailly et al., 2004). In patients with major depressive
disorders, the decreased level of GABA has been reported
in plasma, CSF, and cortex neurons in comparison with the
normal subjects (Rajkowska et al., 2007; Maciag et al., 2010).
According to knockout mice model studies, the changes in
5-HT1B receptor expression and signaling were observed in
the depression model (Lanfumey and Hamon, 2004; Lanfumey
et al., 2008; Fakhoury, 2015). The lack of neurotransmitters
subsequently alters the second messenger response in cells
(Shimon et al., 1997; Coupland et al., 2005). Furthermore,
several studies founded that the density of postsynaptic 5-HT
receptors is markedly attenuated in patients with depression
(Bhagwagar et al., 2004; Drevets et al., 2007). Recent studies
demonstrated that SIRT1 affects the levels of neurotransmitter
by modulating the mono-amine oxidases MAO-A promoter
(Libert et al., 2011) and finally plays a beneficial role in
the anxiety and depression (Nordquist and Oreland, 2010).
The activation of SIRT1 also contributes to the regulation
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of GABA secretion (Prud’Homme et al., 2014). In addition,
SIRT2 is involved in motor dysfunction in patients with
neurodegenerative disease by decreasing dopamine content in
the brain striatum (Wang et al., 2015). SIRT4 has been reported
that it could modulate glutamate uptake in CNS (Shih et al.,
2014).
In addition, depression is influenced by reduced levels and
activity of acetylcholine (Caspi et al., 2003; Meerson et al.,
2010). Current study demonstrated that mood and anxiety
were regulated by acetylcholine pathway (Picciotto et al.,
2015). Several studies suggested that SIRT1 could involve in
acetylcholine receptor expression in brain (Huang et al., 2011)
and modulates choline’s expression (Gareri et al., 2015). Taken
together, SIRTs is involved in the level of neurotransmitters
in CNS based on recent evidences. Hence, we suggest that
SIRTs should be more highlighted the role of it regarding
neurotransmitters in depression brain (Figure 1).
SIRTUINS AND SYNAPTIC DYSFUNCTION
IN DEPRESSION
A loss of synaptic plasticity is commonly observed in patients
with depression (Raison et al., 2006; Martinowich et al.,
2007). Current clinic study demonstrated that the synaptic
dysfunction is strongly influenced by depressive emotional
states (McGaugh, 2000; Banasr and Duman, 2007; Kauer and
Malenka, 2007; Pittenger and Duman, 2008; Russo and Nestler,
2013). Stress, leading to depression triggers the alteration of
presynaptic glutamate secretion and postsynaptic glutamate
receptor expression (Yuen et al., 2009). Depression also affects
the dendrite spines and finally memory acquisition and long term
plasticity (Alvarez and Sabatini, 2007). Recent study reported that
SIRT1 affects dendritic development in hippocampal neurons
(Braidy et al., 2012). In SIRT1 knockoutmice, dendrite branching
and branch length of neuron decreased compared to the normal
brain (Michan et al., 2010) and impaired synapse plasticity
was founded in the hippocampus (Gao et al., 2010). The
activity of SIRT1 in dendritic development is related with
the Rho GTPases and the ROCK signaling in hippocampal
neuron (Negishi and Katoh, 2002; Codocedo et al., 2012).
Several studies indicate that the activity of SIRT1 protects the
several synaptic proteins in various neurodegenerative diseases
(Duan and Mattson, 1999; Patel et al., 2005; Kim et al., 2007).
Collectively, SIRTs are associated with the synaptic dysfunction
and may contribute to the improvement of synapse plasticity in
depression (Figure 1).
SIRTUINS AND METABOLIC SYNDROME
WITH DEPRESSION
Recently, the elevated level of metabolic factors including
blood pressure, cholesterol, C-reactive protein leading to T2DM
or obesity (Ali et al., 2006; Barnard et al., 2006) has been
considered as the higher risk for depressive symptoms (Hamer
et al., 2012; Rotella and Mannucci, 2013). High glucose
and insulin resistance in T2DM affect negatively the brain
(van Duinkerken et al., 2012a; Antenor-Dorsey et al., 2013;
Reijmer et al., 2013) because it aggravates the functional
FIGURE 1 | The involvement between Sirtuins (SIRTs) and depression. This schematic image shows the relevance between SIRTs and depression. The onset
and progress of depression is related with the inflammation, improper neurotransmitter’s secretion, and synaptic dysfunction. This image indicates the involvement
of SIRTs in these mechanisms. Mets: Metabolic disorders.
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dysconnectivity of brain (Geissler et al., 2003; Sahin et al., 2008;
Musen et al., 2012; van Duinkerken et al., 2012b). Hyperglycemia
induces the dysregulation of hypothalamic pituitary-adrenal
axis and dysregulation of monoaminergic system (Zanoveli
et al., 2015). Several studies reported that the patients with
obesity and depression have more frequency in comparison
with the general population (McIntyre et al., 2007; Blaine,
2008; Luppino et al., 2010; Levitan et al., 2012; Toups et al.,
2013). According on previous published evidences, SIRT1 is
strongly related with neuropathgenesis caused by T2DM and
obesity. SIRT1 has been reported that it plays a cardinal
role in glucose metabolism and insulin signaling activation
(Guarente, 2006; Barzilai et al., 2012; Wang et al., 2012;
Mortuza et al., 2013; Silvestre et al., 2014). The regulation
of glucose metabolism is an important issue for anti-aging
according several evidences (Colman et al., 2009; Smith
et al., 2010). The regulation of glucose metabolism has been
demonstrated to suppress against onset age related diseases
(Colman et al., 2009; Smith et al., 2010) such as the T2DM
and cardiovascular disease (Hammer et al., 2008; Marchal
et al., 2012) and especially is associated with the activity
of AMPK and SIRT1 related with the NAD+ biosynthetic
activity (Yang et al., 2007) and SIRT6 associated with the
regulation of insulin mediated signaling (Xiao et al., 2010).
SIRTs improved insulin secretion and glucose homeostasis
(Revollo et al., 2007; Caron et al., 2014) via increasing
NAD+ levels (Schenk et al., 2011). Based on the study
using SIRT6 (−/−) animals, the deficiency of SIRT6 showed
the changes of blood glucose level (Xiao et al., 2010). In
addition, in neurons, SIRT1 signaling modulates peroxisome
proliferator-activated receptor γ coactivator-1 (PGC-1α) activity
and subsequently mitochondrial dysfunction (Chowdhury et al.,
2011). SIRT2 also has been reported that it is target for
diabetes (Nerurkar and Nerurkar, 2008). Taken together, SIRTs
family is associated with the metabolic diseases including the
T2DM and obesity and affect neuropathogenesis caused by these
disorders (Hamer et al., 2012; Rotella and Mannucci, 2013).
Taken together, SIRTs is involved in the progress of depressive
symptoms caused by metabolic disease (Figure 2). Considering
sirtuin’s neuroprotective effects including anti-inflammatory
FIGURE 2 | The association between depression and metabolic diseases. This schematic image shows the association between depression and metabolic
diseases. SIRTs are involved in the pathogenesis of metabolic disease by metabolic changes and also are related with depression related phenomenon. This image
indicates the importance of SIRTs in mechanisms between depression and metabolic diseases. Mets: Metabolic disorders.
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effect, regulation of neurotransmitter production, and reduction
of synaptic dysfunction, SIRTs could be a crucial target to
ameliorate depressive pathology by metabolic alterations.
CONCLUSIONS AND FUTURE
PERSPECTIVES
In conclusion, we suggest that SIRTs are promising therapeutic
targets to alleviate depression pathology in four possibilities:
(1) SIRTs may control the inflammatory response in
depression; (2) SIRTs might regulate the insufficient level
of neurotransmitters in depression; (3) SIRTs may improve
the synaptic dysfunction caused by depression; and (4) sirtuis
may alleviate the cognitive decline caused by depression. As
society ages, people suffer from metabolic syndrome such as
diabetes, obesity, and cardiovascular disease and subsequently
they suffer from depression by metabolic changes. We should
investigate to search the therapeutic solution. SIRTs is the
metabolism related genes and also ameliorates depression
related pathogenesis (Abe et al., 2011; Ferland et al., 2013;
Krogh et al., 2014). SIRTs may be a good target to modulate
various pathogenesis in depression related with metabolic
diseases. Although sirtuin’s mechanisms in depression is fully
not understood until now, researchers continuously have
investigated the novel role of SIRTs such as the regulation
of microRNAs by SIRTs (Rao et al., 2013; Deng et al., 2014;
Rodriguez-Ortiz et al., 2014). Thus, we propose the necessity
of further studies regarding sirtuin’s role, suggesting that
manipulation of siutuins may be a therapeutic solution for
depression.
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